Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
European Journal of Pharmacology|September 26, 2015
Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in miceMarta Zielińska, Tanila Ben Haddou, Gerta Cami-Kobeci, et al.
European Journal of Pharmacology|March 1, 2005
BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonismStephen M Husbands, Claire L Neilan, Jillian Broadbear, et al.
European Journal of Pharmacology|September 15, 2004
Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonistClaire L Neilan, Stephen M Husbands, Simon Breeden, et al.
Journal of Medicinal Chemistry|April 22, 2015
C7β-methyl analogues of the orvinols: the discovery of kappa opioid antagonists with nociceptin/orphanin FQ peptide (NOP) receptor partial agonism and low, or zero, efficacy at mu opioid receptorsJuan Pablo Cueva, Christopher Roche, Mehrnoosh Ostovar, et al.
Drug Testing and Analysis|February 24, 2026
Bromazolam Tablet Quantification and Analysis of Post-Mortem Cases From the National Programme on Substance Use Mortality (NPSUM)Matthew Gardner, Molly F Millea, Sam Craft, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 11, 2012
Imaging imidazoline-I2 binding sites in porcine brain using 11C-BU99008Steven Kealey, Emma M Turner, Stephen M Husbands, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2020
Pharmacological Properties of δ-Opioid Receptor-Mediated Behaviors: Agonist Efficacy and Receptor ReserveIsaac J Dripps, Ruizhuo Chen, Amanda M Shafer, et al.
Synapse (New York, N.Y.)|February 1, 2012
Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding siteRobin J Tyacke, Amy Fisher, Emma S J Robinson, et al.
Journal of Medicinal Chemistry|March 4, 2009
Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexaminesGerta Cami-Kobeci, Adrian P Neal, Faye A Bradbury, et al.
British Journal of Anaesthesia|March 28, 2019
BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primatesNorikazu Kiguchi, Huiping Ding, Gerta Cami-Kobeci, et al.
Pageof 11